-
Je něco špatně v tomto záznamu ?
DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population
M. Belickova, MD. Merkerova, E. Stara, J. Vesela, D. Sponerova, D. Mikulenkova, R. Brdicka, R. Neuwirtova, A. Jonasova, J. Cermak,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem
Grantová podpora
NT13899
MZ0
CEP - Centrální evidence projektů
NLK
BioMedCentral
od 2008-01-12
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Medline Complete (EBSCOhost)
od 2009-01-17
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
PubMed
23339595
DOI
10.1186/1756-8722-6-9
Knihovny.cz E-zdroje
- MeSH
- DNA nádorová genetika MeSH
- dospělí MeSH
- enzymy opravy DNA genetika MeSH
- genetická predispozice k nemoci MeSH
- genotyp MeSH
- jednonukleotidový polymorfismus genetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- míra přežití MeSH
- mladiství MeSH
- mladý dospělý MeSH
- myelodysplastické syndromy epidemiologie etiologie mortalita MeSH
- oprava DNA genetika MeSH
- polymerázová řetězová reakce MeSH
- prognóza MeSH
- rizikové faktory MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- studie případů a kontrol MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Interactions between genetic variants and risk factors in myelodysplastic syndromes are poorly understood. In this case-control study, we analyzed 1 421 single nucleotide polymorphisms in 408 genes involved in cancer-related pathways in 198 patients and 292 controls. METHODS: The Illumina SNP Cancer Panel was used for genotyping of samples. The chi-squared, p-values, odds ratios and upper and lower limits of the 95% confidence interval were calculated for all the SNPs that passed the quality control filtering. RESULTS: Gene-based analysis showed nine candidate single nucleotide polymorphisms significantly associated with the disease susceptibility (q-value<0.05). Four of these polymorphisms were located in oxidative damage/DNA repair genes (LIG1, RAD52, MSH3 and GPX3), which may play important roles in the pathobiology of myelodysplastic syndromes. Two of nine candidate polymorphisms were located in transmembrane transporters (ABCB1 and SLC4A2), contributing to individual variability in drug responses and patient prognoses. Moreover, the variations in the ROS1 and STK6 genes were associated with the overall survival of patients. CONCLUSIONS: Our association study identified genetic variants in Czech population that may serve as potential markers for myelodysplastic syndromes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031692
- 003
- CZ-PrNML
- 005
- 20191025084843.0
- 007
- ta
- 008
- 131002s2013 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/1756-8722-6-9 $2 doi
- 035 __
- $a (PubMed)23339595
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Beličková, Monika $u Institute of Hematology and Blood Transfusion, U Nemocnice 1, Prague, Czech Republic. monika.belickova@uhkt.cz $7 xx0099634
- 245 10
- $a DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population / $c M. Belickova, MD. Merkerova, E. Stara, J. Vesela, D. Sponerova, D. Mikulenkova, R. Brdicka, R. Neuwirtova, A. Jonasova, J. Cermak,
- 520 9_
- $a BACKGROUND: Interactions between genetic variants and risk factors in myelodysplastic syndromes are poorly understood. In this case-control study, we analyzed 1 421 single nucleotide polymorphisms in 408 genes involved in cancer-related pathways in 198 patients and 292 controls. METHODS: The Illumina SNP Cancer Panel was used for genotyping of samples. The chi-squared, p-values, odds ratios and upper and lower limits of the 95% confidence interval were calculated for all the SNPs that passed the quality control filtering. RESULTS: Gene-based analysis showed nine candidate single nucleotide polymorphisms significantly associated with the disease susceptibility (q-value<0.05). Four of these polymorphisms were located in oxidative damage/DNA repair genes (LIG1, RAD52, MSH3 and GPX3), which may play important roles in the pathobiology of myelodysplastic syndromes. Two of nine candidate polymorphisms were located in transmembrane transporters (ABCB1 and SLC4A2), contributing to individual variability in drug responses and patient prognoses. Moreover, the variations in the ROS1 and STK6 genes were associated with the overall survival of patients. CONCLUSIONS: Our association study identified genetic variants in Czech population that may serve as potential markers for myelodysplastic syndromes.
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a studie případů a kontrol $7 D016022
- 650 _2
- $a oprava DNA $x genetika $7 D004260
- 650 _2
- $a enzymy opravy DNA $x genetika $7 D045643
- 650 _2
- $a DNA nádorová $x genetika $7 D004273
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genetická predispozice k nemoci $7 D020022
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a myelodysplastické syndromy $x epidemiologie $x etiologie $x mortalita $7 D009190
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a jednonukleotidový polymorfismus $x genetika $7 D020641
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a míra přežití $7 D015996
- 650 _2
- $a mladý dospělý $7 D055815
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Dostálová, Michaela $u - $7 xx0164071
- 700 1_
- $a Stara, Eliska $u -
- 700 1_
- $a Veselá, Jitka $u - $7 xx0209625
- 700 1_
- $a Šponerová, Dana $u - $7 xx0127224
- 700 1_
- $a Mikulenková, Dana $u - $7 xx0182877
- 700 1_
- $a Brdička, Radim, $u - $d 1933- $7 jk01013054
- 700 1_
- $a Neuwirtová, Radana, $u - $d 1927- $7 jk01090111
- 700 1_
- $a Jonášová, Anna $u - $7 xx0103767
- 700 1_
- $a Čermák, Jaroslav, $u - $d 1954- $7 xx0053072
- 773 0_
- $w MED00165458 $t Journal of hematology & oncology $x 1756-8722 $g Roč. 6(2013), s. 9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23339595 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20131002 $b ABA008
- 991 __
- $a 20191025085319 $b ABA008
- 999 __
- $a ok $b bmc $g 995779 $s 830137
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 6 $d 9 $i 1756-8722 $m Journal of hematology & oncology $n J Hematol Oncol $x MED00165458
- GRA __
- $a NT13899 $p MZ0
- LZP __
- $a Pubmed-20131002